Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...
The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...
People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...
A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.
EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...